- Home
- HAE
HAE
Haemonetics Corporation
as 05-08-2025 4:00pm EST
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | N/A | IPO Year: | 1991 |
| Target Price: | $100.89 | AVG Volume (30 days): | 580.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.31 | EPS Growth: | 44.54 |
| 52 Week Low/High: | $55.30 - $97.97 | Next Earning Date: | 05-08-2025 |
| Revenue: | $1,360,824,000 | Revenue Growth: | 3.96% |
| Revenue Growth (this year): | -1.31% | Revenue Growth (next year): | 8.41% |
Latest Haemonetics Corporation News
HAE Breaking Stock News: Dive into HAE Ticker-Specific Updates for Smart Investing
MT Newswires
11 hours ago
Haemonetics' Fiscal Q4 Adjusted Earnings Rise, Revenue Falls; Fiscal 2026 Outlook Issued
Associated Press Finance
12 hours ago
Haemonetics: Fiscal Q4 Earnings Snapshot
StockStory
14 hours ago
Haemonetics (NYSE:HAE) Surprises With Q1 Sales
PR Newswire
14 hours ago
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Zacks
a day ago
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates
GuruFocus.com
a day ago
Earnings To Watch: Haemonetics Corp (HAE) Reports Q4 2025 Result
Zacks
a day ago
Gear Up for Haemonetics (HAE) Q4 Earnings: Wall Street Estimates for Key Metrics
StockStory
2 days ago
Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect
Compare HAE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HAE Haemonetics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.